Analyzing differences between restricted mean survival time curves using pseudo-values

10/30/2020
by   Federico Ambrogi, et al.
0

Hazard ratios are ubiquitously used in time to event analysis to quantify treatment effects. Although hazard ratios are invaluable for hypothesis testing, other measures of association, both relative and absolute, may be used to fully elucidate study results. Restricted mean survival time differences between groups have been advocated as useful measures of association. Recent work focused on model-free estimates of the difference in restricted mean survival for all follow-up times instead of focusing on a single time horizon. In this work a model-based alternative is proposed with estimation using pseudo-values. A simple approach is proposed easily implementable with available software. It is also possible to compute a confidence region for the curve. As a by-product, the parameter 'time until treatment equipoise' (TUTE) is also studied. Examples with crossing survival curves will be used to illustrate the different methods together with some simulations.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
01/31/2021

Nonparametric Analysis of Delayed Treatment Effects using Single-Crossing Constraints

Clinical trials involving novel immuno-oncology (IO) therapies frequentl...
research
11/25/2021

A framework for meta-analysis through standardized survival curves

Meta-analyses of survival studies aim to reveal the variation of an effe...
research
11/01/2022

Comparison of Baseline Covariate Adjustment Methods for Restricted Mean Survival Time

The restricted mean survival time is a clinically easy-to-interpret meas...
research
06/24/2023

Analysis of dynamic restricted mean survival time based on pseudo-observations

In clinical follow-up studies with a time-to-event end point, the differ...
research
10/17/2018

Mean survival by ordered fractions of population with censored data

We propose a novel approach for estimating mean survival time in the pre...
research
02/21/2020

Efficient model-based Bioequivalence Testing

The classical approach to analyze pharmacokinetic (PK) data in bioequiva...
research
06/28/2023

A Comprehensive Framework for Evaluating Time to Event Predictions using the Restricted Mean Survival Time

The restricted mean survival time (RMST) is a widely used quantity in su...

Please sign up or login with your details

Forgot password? Click here to reset